S

Sreeparvathy

Active Director Director DIN 09471580
DIN 09471580 First appointment Jan 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value •••• Premium profile

About Sreeparvathy

Data last updated:

Sreeparvathy is a Director at Dr.Sudarsan's Ayurveda Private Limited (since 2022). The company operates in Healthcare. Dr.Sudarsan's Ayurveda Private Limited reported revenue of ₹2.7 Lakh (FY 2024).

DIN 09471580
Primary Designation Director
Industry Healthcare
First Appointment 18 Jan 2022
Oldest Company Age 4 yrs
Largest company Dr.Sudarsan's Ayurveda Private Limited · ₹2.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jan 20222022₹2.7 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Dr.Sudarsan's Ayurveda Private Limited
Premium access

Shareholding and investment profile for Sreeparvathy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sreeparvathy

Sreeparvathy currently holds 1 directorship: Dr.Sudarsan's Ayurveda Private Limited (Director, since 18 Jan 2022, revenue ₹2.7 Lakh (FY 2024)).

Sreeparvathy was first appointed on 18 Jan 2022 as Director at Dr.Sudarsan's Ayurveda Private Limited.

The current boards of Sreeparvathy's companies include Kinarath Narayanan Chanakath Sathyanarayanan (Dr.Sudarsan's Ayurveda Private Limited), Puthenveettil Kesavan Nair Sudarsanannair (Dr.Sudarsan's Ayurveda Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available